Clinical trial
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00339859 |
|---|---|
| Title | DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer |
| Official title | DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Lung Neoplasms |
| Enrollment | 5,625 |
| Start date | Jun 2, 1995 |
| Primary completion | May 6, 2020 |
| Completion | May 6, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | May 11, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: